Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
13 participants
OBSERVATIONAL
2016-06-06
2021-05-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Beta Cell Imaging in T1D Patients With a Different Glycemic Control
NCT03785275
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
NCT05622123
Identification of β Cell Dysfunction in Relatives of Individuals With Type 1 Diabetes Mellitus
NCT04362917
Imaging of Type 1 Diabetes Progression
NCT01521520
Adipose Tissue Imaging in Type 2 Diabetes
NCT02528695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tx-group
T1D patients that received islet of Langerhans transplantation (Tx) at least 3 months earlier
68Ga-NODAGA-exendin PET/CT
68Ga-NODAGA-exendin PET/CT
Control group
T1D patients that await islet of Langerhans transplantation
68Ga-NODAGA-exendin PET/CT
68Ga-NODAGA-exendin PET/CT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
68Ga-NODAGA-exendin PET/CT
68Ga-NODAGA-exendin PET/CT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>18 years old
* T1D patient undergone islet transplantation
* Clinically proven functional islet graft
* Signed informed consent
Control group:
* \>18 years old
* T1D patients who are on the waiting list for islet transplantation
* Signed informed consent
Exclusion Criteria
* Breast feeding
* Pregnancy or the wish to become pregnant within 6 months
* Kidney disease
* Liver disease
* Age \<18 years
* No signed informed consent
* fragments, clips or devices in brain, eyes, spinal canal
* Implantable defibrillator or pacemaker (wires)
* Mandibular magnetic implants
* Neurostimulator, bladder stimulator, non-removable insulin pump
* Metal tissue-expander in chest
* Cochlear implant
* Ossicular replacement prosthesis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radboud university medical center
Nijmegen, Gelderland, Netherlands
Uppsala University Hospital
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL52630.091.15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.